Literature DB >> 7571837

Implementation in Italy of a universal vaccination programme against hepatitis B.

P Bonanni1.   

Abstract

Italy was the first industrialized country to introduce mass vaccination against hepatitis B. Following the collection of epidemiological data on age-specific incidence rates of infection, a law was issued in 1991 which established mandatory immunization of neonates and 12-year-old adolescents. This strategy will lead to the protection of all subjects aged 0-24 years within 12 years and to the elimination of circulation of hepatitis B virus (HBV) in a few decades. The first data on compliance with vaccination, both in infants and in adolescents, indicate the success of the programme, which was helped by good vaccination delivery services and awareness of the risks of hepatitis B both by physicians and the public. A multi-centre study on protective antibody level and kinetics over time is in progress. Preliminary results show an excellent response to vaccination. High-risk strategies will continue by actively offering HBV vaccination free of charge to all those exposed to infection via occupation or life-style. The Italian policy of universal vaccination against HBV can therefore be regarded as a model for the introduction of mass immunization into other countries.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7571837     DOI: 10.1016/0264-410x(95)80058-l

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  5 in total

1.  The response of hepatitis B vaccination on seronegative adults with different vaccination schedules.

Authors:  Jun Yao; Jing Li; Yongdi Chen; Huan Shan; Xue-wei Dai; Lin-na Yang; Zheng-gang Jiang; Jing-jing Ren; Kai-jin Xu; Bing Ruan; Shi-gui Yang; Bing Wang; Tian-sheng Xie; Qian Li
Journal:  Hum Vaccin Immunother       Date:  2015       Impact factor: 3.452

2.  Immunological effects of a 10-μg dose of domestic hepatitis B vaccine in adults.

Authors:  Jing-jing Ren; Xue-wei Dai; Zheng-gang Jiang; Ling-zhi Shen; Yong-di Chen; Qian Li; Wen Ren; Ying Liu; Jun Yao; Lan-juan Li
Journal:  J Zhejiang Univ Sci B       Date:  2012-11       Impact factor: 3.066

3.  Need to take special care of non-responders to hepatitis B vaccination among health-care workers, students and chronic patients.

Authors:  Angela Bechini; Paolo Bonanni; Maddalena Grazzini; Diana Paolini; Giulio Arcangeli; Nicola Mucci; Costanza Bini; Emilia Tiscione; Beatrice Zanella; Sara Boccalini
Journal:  Hum Vaccin Immunother       Date:  2020-12-03       Impact factor: 3.452

4.  Sero-epidemiology of hepatitis B markers in the population of Tuscany, Central Italy, 20 years after the implementation of universal vaccination.

Authors:  Sara Boccalini; Elettra Pellegrino; Emila Tiscione; Giovanna Pesavento; Angela Bechini; Miriam Levi; Stefano Rapi; Stefano Mercurio; Francesco Mannelli; Marta Peruzzi; Cesare Berardi; Paolo Bonanni
Journal:  Hum Vaccin Immunother       Date:  2013-01-25       Impact factor: 3.452

5.  Vaccination against hepatitis A in children: A review of the evidence.

Authors:  Paolo Bonanni; Sara Boccalini; Angela Bechini
Journal:  Ther Clin Risk Manag       Date:  2007-12       Impact factor: 2.423

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.